US2003203835A1PendingUtilityA1

High throughput sarcomeric assay

Assignee: CYTOKINETICS INCPriority: Mar 29, 2000Filed: Apr 15, 2003Published: Oct 30, 2003
Est. expiryMar 29, 2020(expired)· nominal 20-yr term from priority
C12Q 1/34A61K 38/00C12Q 1/37C12Q 1/42G01N 33/6887G01N 33/6893G01N 2333/914G01N 2500/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides high throughput screening systems for identifying compounds that modulate the biological activity of a biochemically functional sarcomere. The method can be performed in plurality simultaneously with fluorescence or absorbance readouts.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of identifying a candidate agent as a modulator of function of a target protein complex wherein said target protein complex comprises a biochemically functional sarcomere and said method comprises: 
 a) adding a candidate agent to a mixture comprising a target protein complex that directly or indirectly produces ADP or phosphate under conditions which normally allow the production of ADP or phosphate;    b) subjecting the mixture to an enzymatic reaction that uses said ADP or phosphate as a substrate under conditions which normally allow the ADP or phosphate to be utilized; and    c) determining the level of activity of the enzymatic reaction wherein a change in said level between the presence and absence of said candidate agent indicates a modulator of said target protein function.    
     
     
         2 . The method of  claim 1 , wherein said determining occurs by a fluorescent, luminescent, radioactive, or absorbance readout.  
     
     
         3 . The method of  claim 1 , wherein said level of activity of said enzymatic reaction is determined at multiple time points.  
     
     
         4 . The method of  claim 1 , wherein a plurality of candidate agents are added.  
     
     
         5 . The method of  claim 1 , wherein said target protein complex directly produces phosphate or ADP.  
     
     
         6 . The method of  claim 1 , wherein said target protein complex comprises a mixture of myosin, actin, and cardiac regulatory proteins.  
     
     
         7 . The method of  claim 6 , wherein said candidate agent activates myosin.  
     
     
         8 . The method of  claim 6 , wherein said candidate agent modulates a cardiac regulatory protein.  
     
     
         9 . The method of  claim 1 , wherein the enzymatic reaction occurs at a calcium concentration below pCa equal to 4.  
     
     
         10 . The method of  claim 1 , wherein the enzymatic reaction occurs at a calcium concentration of about pCa equal to 4.  
     
     
         11 . The method of  claim 1 , wherein the enzymatic reaction occurs at a calcium concentration of about pCa equal to 6.5.  
     
     
         12 . The method of  claim 1 , wherein the enzymatic reactions occurs in the presence of EGTA.  
     
     
         13 . The method of  claim 1 , wherein the target protein complex comprises actin and myosin.  
     
     
         14 . A composition comprising an isolated biochemically functional sarcomere, wherein said sarcomere exhibits calcium regulated myosin ATPase activity  
     
     
         15 . The composition of  claim 12 , wherein said sarcomere comprises myosin, actin, and regulatory proteins.  
     
     
         16 . The composition of  claim 13 , wherein said actin is bovine.  
     
     
         17 . The composition of  claim 13 , wherein said regulatory proteins are from a human.

Join the waitlist — get patent alerts

Track US2003203835A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.